181 related articles for article (PubMed ID: 26367001)
1. Effect of Trimetazidine in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis.
Zhang Y; Ma XJ; Shi DZ
PLoS One; 2015; 10(9):e0137775. PubMed ID: 26367001
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Trimetazidine in Limiting Periprocedural Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
Wang C; Chen W; Yu M; Yang P
Angiology; 2021 Jul; 72(6):511-523. PubMed ID: 33472383
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention.
Bonello L; Sbragia P; Amabile N; Com O; Pierre SV; Levy S; Paganelli F
Heart; 2007 Jun; 93(6):703-7. PubMed ID: 17488771
[TBL] [Abstract][Full Text] [Related]
4. Is treatment with trimetazidine beneficial in patients with chronic heart failure?
Zhou X; Chen J
PLoS One; 2014; 9(5):e94660. PubMed ID: 24797235
[TBL] [Abstract][Full Text] [Related]
5. The effect of trimetazidine treatment in patients with type 2 diabetes undergoing percutaneous coronary intervention for AMI.
Li R; Tang X; Jing Q; Wang Q; Yang M; Han X; Zhao J; Yu X
Am J Emerg Med; 2017 Nov; 35(11):1657-1661. PubMed ID: 28587952
[TBL] [Abstract][Full Text] [Related]
6. Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention-induced myocardial injury.
Kazmi DH; Kapoor A; Sinha A; Ambesh P; Kashyap S; Khanna R; Kumar S; Garg N; Tewari S; Goel PK
Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S365-S371. PubMed ID: 30595291
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the myocardial protection of trimetazidine during percutaneous coronary intervention: a multi-center randomized and controlled clinical study].
Chen YD; Zhao LK; Tian F; Du ZM; Jiang H; Wei M
Zhonghua Nei Ke Za Zhi; 2010 Jun; 49(6):473-6. PubMed ID: 20979731
[TBL] [Abstract][Full Text] [Related]
8. Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention.
Labrou A; Giannoglou G; Zioutas D; Fragakis N; Katsaris G; Louridas G
Am J Cardiovasc Drugs; 2007; 7(2):143-50. PubMed ID: 17503885
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of trimetazidine in angina pectoris by echocardiography and radionuclide angiography: a meta-analysis of randomized, controlled trials.
Hu B; Li W; Xu T; Chen T; Guo J
Clin Cardiol; 2011 Jun; 34(6):395-400. PubMed ID: 21538382
[TBL] [Abstract][Full Text] [Related]
10. Effect of Trimetazidine on Diabetic Patients with Coronary Heart Diseases: A Meta-Analysis of Randomized, Controlled Trials.
Lin Y; Wang ZL; Yan M; Zhu FY; Duan Y; Sun ZQ
Chin Med Sci J; 2020 Sep; 35(3):226-238. PubMed ID: 32972500
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of trimetazidine on stable angina pectoris: a meta-analysis of randomized clinical trials.
Peng S; Zhao M; Wan J; Fang Q; Fang D; Li K
Int J Cardiol; 2014 Dec; 177(3):780-5. PubMed ID: 25466565
[TBL] [Abstract][Full Text] [Related]
12. Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis.
Zhang L; Lu Y; Jiang H; Zhang L; Sun A; Zou Y; Ge J
J Am Coll Cardiol; 2012 Mar; 59(10):913-22. PubMed ID: 22381427
[TBL] [Abstract][Full Text] [Related]
13. Trimetazidine improves exercise tolerance in patients with ischemic heart disease : A meta-analysis.
Zhao Y; Peng L; Luo Y; Li S; Zheng Z; Dong R; Zhu J; Liu J
Herz; 2016 Sep; 41(6):514-22. PubMed ID: 26668006
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
[TBL] [Abstract][Full Text] [Related]
15. Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial.
Wu L; Luan Y; Li Y; Wang M; He J; Jin C; Zhang W
BMC Cardiovasc Disord; 2020 Jun; 20(1):273. PubMed ID: 32503494
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy.
Di Napoli P; Di Giovanni P; Gaeta MA; D'Apolito G; Barsotti A
Am Heart J; 2007 Sep; 154(3):602.e1-5. PubMed ID: 17719313
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous coronary intervention for poor coronary microcirculation reperfusion of patients with stable angina pectoris.
Li JS; Zhao XJ; Ma BX; Wang Z
J Biol Regul Homeost Agents; 2016; 30(3):733-741. PubMed ID: 27655490
[TBL] [Abstract][Full Text] [Related]
18. Effect of trimetazidine on incidence of major adverse cardiac events in coronary artery disease patients undergoing percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
Zhu K; Zheng YS; Fang Y
Medicine (Baltimore); 2020 Oct; 99(44):e22918. PubMed ID: 33126352
[TBL] [Abstract][Full Text] [Related]
19. [Effects of trimetazidine therapy on left ventricular function after percutaneous coronary intervention].
Xu XH; Zhang WJ; Zhou YJ; Zhou ZM; Ma HY; Hu B; Kang YP; Luo FF
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Mar; 41(3):205-9. PubMed ID: 23879944
[TBL] [Abstract][Full Text] [Related]
20. Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials.
Kumbhani DJ; Bavry AA; Desai MY; Bangalore S; Bhatt DL
J Am Coll Cardiol; 2013 Oct; 62(16):1409-18. PubMed ID: 23665372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
